Overview
- 104 inspections across 91 sites are on record.
- 214 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2015-10-07.
At a glance
Inspections
104
Sites
91
Observations
214
Career since
Feb 2009
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Cape Drugs | 7 Oct 2015 | Human Drugs | On file |
| Phibro Animal Health Corporation | 18 Sep 2015 | Animal Drugs & Feeds | On file |
| Reliance Life Sciences Private Limited | 14 Aug 2015 | Human Drugs | On file |
| Cipla Limited | 7 Aug 2015 | Human Drugs | View 483 → |
| Sentara Enterprises Inc., dba Sentara Home Infusion Pharmacy Services | 23 Jul 2015 | Human Drugs | View 483 → |
Sites inspected
Cape DrugsAnnapolis, United States1 insp.
Phibro Animal Health CorporationSalisbury, United States1 insp.
Reliance Life Sciences Private LimitedNavi Mumbai, India1 insp.
Cipla LimitedPithampur, District Dhar, India1 insp.
Sentara Enterprises Inc., dba Sentara Home Infusion Pharmacy ServicesChesapeake, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Rachel C Harrington7 shared
Jesse P Hardin7 shared
Brooke K Higgins6 shared
Monique-Rac Lester4 shared
Junho Pak3 shared
Ernest Bizjak3 shared
Julianne C Mccullough3 shared
Cynthia A Harris3 shared
Pratik S Upadhyay2 shared
Ademola O Daramola2 shared
Full investigator report
Get the verbatim findings behind Nebil A Oumer's 214 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site